Prudent Man Advisors LLC Sells 6,245 Shares of SPDR S&P Biotech ETF $XBI

Prudent Man Advisors LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 44.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,783 shares of the exchange traded fund’s stock after selling 6,245 shares during the period. Prudent Man Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $780,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. AdvisorNet Financial Inc grew its stake in SPDR S&P Biotech ETF by 7.3% in the 3rd quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock worth $147,000 after acquiring an additional 100 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of SPDR S&P Biotech ETF by 3.1% during the third quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock valued at $340,000 after acquiring an additional 101 shares in the last quarter. Kingsview Wealth Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 1.8% in the third quarter. Kingsview Wealth Management LLC now owns 5,813 shares of the exchange traded fund’s stock valued at $582,000 after purchasing an additional 103 shares during the period. CWC Advisors LLC. boosted its holdings in shares of SPDR S&P Biotech ETF by 2.8% in the third quarter. CWC Advisors LLC. now owns 5,707 shares of the exchange traded fund’s stock valued at $572,000 after purchasing an additional 157 shares during the period. Finally, Mission Hills Financial Advisory LLC grew its stake in SPDR S&P Biotech ETF by 0.4% in the third quarter. Mission Hills Financial Advisory LLC now owns 35,841 shares of the exchange traded fund’s stock worth $3,591,000 after purchasing an additional 157 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.8%

XBI opened at $126.38 on Thursday. The stock’s fifty day moving average is $125.45 and its two-hundred day moving average is $114.72. The company has a market capitalization of $8.44 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $132.09.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.